Mdt Tonic

Medtronic Launches New Products For Spine Surgery

Posted on May 01, 2018 by Medtech[y] Staff

Medtronic today announced two new exciting developments in their Spine division with the launch of their titanium 3D printed platform, TiONIC Technology, and new spine surgery indications were approved for their infuse Bone Graft.

The TiONIC Technology titanium 3D printed platform enables more complex designs and integrated surface technologies for spine surgery implants. The announcement was made during the American Association of Neurological Surgeons (AANS) annual meeting in New Orleans, La.

InfuseBone Graft is now approved for use with additional spine implants made of polyetheretherketone (PEEK) in oblique lateral interbody fusion (OLIF 25(TM) and OLIF 51(TM)) and anterior lumbar interbody fusion (ALIF) procedures at a single level. This is the second expanded indication in just over two years.

"Surface advancements, like TiONIC Technology, have emerged as a paradigm shift in interbody fusion implants," said Dr. Colin C. Buchanan, neurosurgeon at the Colorado Brain and Spine Institute, in Aurora, Colo. "Implants utilizing newer surface technology can help stimulate a cellular response and give me greater confidence that the patient will have a successful fusion."

"ARTiC-L is an important component of Medtronic's portfolio of reproducible solutions for minimally invasive procedures," said Doug King, senior vice president and president of Medtronic's Spine division, which is part of the Restorative Therapies Group at Medtronic. "Our 3D printed TiONIC Technology allows devices such as ARTiC-L - and our future interbody implant portfolio - to offer surgical advantages not traditionally possible."

How Can 3D Printing Work With Medical Devices?

The new approved indications for InfuseBone Graft are:

  • Use in OLIF 51 procedures with Divergence-L®Interbody Fusion Device at a single level from L5-S1.
  • Use in OLIF 25 procedures with Pivox(TM) Oblique Lateral Spine System at a single level from L2-L5.
  • Use in ALIF procedures with Divergence-LInterbody Fusion Device at a single level from L2-S1.

"Different spine patients can have very different surgical needs, so the more options surgeons have to combine a clinically-proven bone grafting technology like Infuse with different procedures and implants, the greater the likelihood of successful outcomes," said Dr. Richard Hynes, president and spine surgeon at the B.A.C.K. Center in Melbourne, Florida. "This latest approval addresses some fairly common degenerative spine surgical correction needs."

"Infuse Bone Graft remains one of the most-extensively studied products in Spine that is commercially available today," said Doug King, senior vice president and president of Medtronic's Spine division, which is part of the Restorative Therapies Group at Medtronic. "The expanded approval with these PEEK devices for OLIF25, OLIF51, and ALIF procedures provide important options for surgeons and their patients."